For over 50 years, Nasdaq has been a leader in the exchange space through our technology innovations. We built our IPO process in partnership with the investment banking community, ensuring that ...

Drugs Made In America Acquisition Corp. announced the completion of its initial public offering, raising $200 million by selling 20 million units at $10 each, which began trading on Nasdaq under ...

Nasdaq (Nasdaq: NDAQ) announced today that in 2024, it welcomed 171 initial public offerings (IPOs), raising a total of $22.7 billion. A total of 123 operating companies and 48 SPACs listed on ...

Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million. The two-year-old South San Francisco-based ...

The California-based company is set to begin trading on the Nasdaq, with 7.5 million shares priced between $14 and $16 apiece under the ticker BBNX—an IPO range that would give Beta Bionics ...